Environmental Evaluation of a Child with Developmental Disability

Pediatric Clinics of North America

Volumn 54, Issue 1, 2007, Pages 47-62

  Hussain, Javed ^a,b   Woolf, Alan D ^a,b,c   Sandel, Megan ^a,d   Shannon, Michael W ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CAMBRIDGE HOSPITAL   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHELATING AGENT; EDETATE CALCIUM DISODIUM; LEAD; METAL; METHYLMERCURY; PESTICIDE; POLYCHLORINATED BIPHENYL; SUCCIMER;

ALTERNATIVE MEDICINE; ANXIETY; AUTISM; CAREGIVER; CHELATION THERAPY; CHILD; CLINICAL PRACTICE; DEVELOPMENTAL DISORDER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILY COUNSELING; FAMILY HISTORY; GENERAL PRACTITIONER; HUMAN; INTOXICATION; PARENT; PATIENT COUNSELING; PHYSICAL EXAMINATION; PRENATAL PERIOD; REVIEW;

CHELATION THERAPY; CHILD; COUNSELING; DEVELOPMENTAL DISABILITIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL ILLNESS; ETHANOL; HUMANS; LEAD POISONING; MATERNAL WELFARE; METALS, HEAVY; PESTICIDES; POLYCHLORINATED BIPHENYLS;

EID: 33846899510     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2006.11.004     Document Type: Review

References (47)

1. Landrigan P.J. Children's environmental health. Lessons from the past and prospects for the future. Pediatr Clin North Am 48 (2001) 1319-1330
2. Landrigan P.J. Children as a vulnerable population. Int J Occup Med Environ Health 17 (2004) 175-177
3. Matsuzaki K. The holding of "International Symposium on Children's Environmental Health". Nippon Eiseigaku Zasshi 60 (2005) 70-76
4. Dietrich K.N., Eskenazi B., Schantz S., et al. Principles and practices of neurodevelopmental assessment in children: lessons learned from the centers for children's environmental health and disease prevention research. Environ Health Perspect 113 (2005) 1437-1446
5. Mendola P., Selevan S.G., Gutter S., et al. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev 8 (2002) 188-197
6. Rice D., and Barone Jr. S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108 Suppl 3 (2000) 511-533
7. Grandjean P, White R. Neurodevelopmental disorders. In: Children's health and environment: a review of evidence. Environmental Issue Report No. 29. Copenhagen (Denmark): WHO/European Environment Agency; 2002.
8. Schaefer M. Children and toxic substances: confronting a major public health challenge. Environ Health Perspect 102 Suppl 2 (1994) 155-156
9. Landrigan P.J., Suk W.A., and Amler R.W. Chemical wastes, children's health, and the Superfund Basic Research Program. Environ Health Perspect 107 (1999) 423-427
10. Rice C., Schendel D., Cunniff C., et al. Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders. Am J Med Genet C Semin Med Genet 125 (2004) 22-27
11. Rice D.C. Issues in developmental neurotoxicology: interpretation and implications of the data. Can J Public Health 89 Suppl 1 (1998) S31-S41
12. Fact Sheet. CDC Autism Research. May 4, 2006. Available at: http://www.cdc.gov/od/oc/media/transcripts/AutismResearchFactSheet.pdf
13. Odding E., Roebroeck M.E., and Stam H.J. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil 28 (2006) 183-191
14. Szymanski L., and King B.H. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 38 (1999) 5S
15. Adelman H.S. LD: the next 25 years. J Learn Disabil 25 (1992) 17S-31S
16. Pastor PN, Reuben CA. Attention deficit disorder and learning disability: United States, 1997-98. Vital Health Stat 10 2002 May;(206):1-12.
17. Cuffe S.P., Moore C.G., and McKeown R.E. Prevalence and correlates of ADHD symptoms in the National Health Interview Survey. J Atten Disord 9 (2005) 392-401
18. Kessler R.C., Adler L., Barkley R., et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163 4 (2006) 716-723
19. Immunization Safety Review Committee (ISRC). Immunization safety review: vaccines & autism (2004), National Academy of Science, Washington, DC
20. Hviid A., Stellfeld M., Wohlfahrt J., et al. Association between thimerosal containing vaccine and autism. JAMA 290 13 (2003) 1763-1766
21. Parker S., Todd J., Schwartz B., et al. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 115 1 (2005) 200 erratum for Pediatrics 2004; 114(3):793-804.
22. McMahon W.M. Review: vaccines containing thimerosal are not associated with autistic spectrum disorders in children. Evid Based Ment Health 8 1 (2005) 23
23. Agency for Toxic Substances and Disease Registry. Polychorinated bipheynls (PCB) toxicity. In: Case studies in environmental medicine, course SS3067, page 7. Revised September 2000.
24. Hertz-Picciotto I., Charles M.J., James R.A., et al. In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth. Epidemiology 16 (2005) 648-656
25. Rice D.C. Neurotoxicity of lead, methylmercury, and PCBs in relation to the Great Lakes. Environ Health Perspect 103 Suppl 9 (1995) 71-87
26. Grey C.N., Nieuwenhuijsen M.J., and Golding J. The use and disposal of household pesticides. Environ Res 97 (2005) 109-115
27. Dorner G., and Plagemann A. DDT in human milk and mental capacities in children at school age: an additional view on PISA 2000. Neuro Endocrinol Lett 23 (2002) 427-431
28. Parent A.S., Rasier G., Gerard A., et al. Early onset of puberty: tracking genetic and environmental factors. Horm Res 64 Suppl 2 (2005) 41-47
29. Chiriboga C.A. Fetal alcohol and drug effects. Neurologist 9 (2003) 267-279
30. Chiriboga C.A., Bateman D.A., Hauser W.A., et al. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr Neurol 9 2 (1993) 115-119
31. Fell J.M., Reynolds A.P., Meadows N., et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347 (1996) 1218-1221
32. Sells C.J., Robinson N.M., Brown Z., et al. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 125 (1994) S9-S17
33. Goma A., Hu H., Bellinger D., et al. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics 110 (2002) 110-118
34. Davidson P.W., Myers G.J., Weiss B., et al. Prenatal methyl mercury exposure from fish consumption and child development: a review of evidence and perspectives from the Seychelles Child Development Study. Neurotoxicology 27 6 (2006) 1106-1109
35. Streffer C. Bystander effects, adaptive response and genomic instability induced by prenatal irradiation. Mutat Res 568 (2004) 79-87
36. Domingo J.L. Prevention by chelating agents of metal-induced developmental toxicity. Reprod Toxicol 9 (1995) 105-113
37. Lorenz J.M. The outcome of extreme prematurity. Semin Perinatol 25 (2001) 348-359
38. Menkes J.H., and Moser F.G. Neurological examination of the child and infant. In: Menkes, Sarnet, and Maria (Eds). Text book of child neurology. 7th edition (2006), Lippincott Williams & Wilkins 1-2
39. Seidel S., Kreutzer R., Smith D., et al. Assessment of commercial laboratories performing hair mineral analysis. JAMA 285 (2001) 67-72
40. Steindel S.J., and Howanitz P.J. The uncertainty of hair analysis for trace metals. JAMA 285 (2001) 83-85
41. Harkins D.K., and Susten A.S. Hair analysis: exploring the state of the science. Environ Health Perspect 111 (2003) 576-578
42. American Academy of Pediatrics Committee on Children With Disabilities. Technical Report. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001;107.
43. Eisenberg D.M. Advising patients who seek alternative medical therapies. Ann Intern Med 127 (1997) 61-69
44. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279(19):1548-53.
45. Boyer E.W., Kearney S., Shannon M.W., et al. Poisoning from a dietary supplement administered during hospitalization. Pediatrics 109 3 (2002) E49
46. Woolf A.D., Gardiner P., Whelan J., et al. Views of pediatric health care providers on the use of herbs and dietary supplements in children. Clin Pediatr (Phila) 44 (2005) 579-587
47. Woolf A.D. Herbal remedies and children: do they work? Are they harmful?. Pediatrics 112 (2003) 240-246